ArticleBMC gastroenterology2026
Timing of endoscopy and short-term outcomes in cirrhotic patients with acute variceal bleeding: a single-center retrospective study.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThe optimal timing of endoscopy for acute variceal bleeding (AVB) remains uncertain in real-world clinical practice. This study aimed to evaluate the association between endoscopy timing and short-term outcomes in patients with AVB.
methodsWe retrospectively included cirrhotic patients with endoscopically confirmed AVB admitted between January 2020 and April 2025 who underwent endoscopic therapy during hospitalization. Patients were categorized according to time from admission to endoscopy: <24 h, 24-72 h, and ≥ 72 h. The primary outcomes were 6-week mortality and rebleeding. Secondary outcomes included length of hospital stay, hospitalization cost, and transfusion requirements. Multivariable logistic regression, Firth penalized logistic regression, subgroup analyses, and sensitivity analyses were performed.
resultsA total of 213 patients were included. Compared with endoscopy within 24 h, endoscopy at 24-72 h was associated with higher odds of 6-week mortality (aOR 21.7, 95% CI 2.50-390, p = 0.003) and rebleeding (aOR 3.35, 95% CI 1.12-11.0, p = 0.036). Endoscopy at ≥ 72 h was associated with higher odds of 6-week mortality in the main model (aOR 9.77, 95% CI 1.12-172, p = 0.038), but this association was less consistent across sensitivity analyses. Sensitivity analyses generally supported the association observed for the 24-72 h group. For secondary outcomes, delayed endoscopy was associated with longer hospital stay, whereas endoscopy at 24-72 h was associated with lower transfusion requirements.
conclusionsEndoscopy timing was associated with short-term outcomes in patients with AVB. Endoscopy at 24-72 h was associated with higher odds of 6-week mortality and rebleeding compared with endoscopy within 24 h, whereas findings for endoscopy beyond 72 h were less consistent across sensitivity analyses. These findings support individualized endoscopy timing after adequate resuscitation and stabilization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.